The purpose of this study is to evaluate the physiological and/or biological actions of nicotinamide mononucleotide (NMN-C) in healthy adults receiving a repeated-dose over the course of 28 days by studying the tolerance and pharmacodynamics of this product.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
17
Nicotinamide mononucleotide (NMN-C) at 400 mg/day for 28 days in total
Biomed 21
Dijon, France
Change from baseline in NAD+ concentrations in whole blood
Time frame: Day 0, Day 14 and Day 28
Change from baseline in NMN concentrations in whole blood
Time frame: Day 0, Day 14 and Day 28
Change from baseline NAD+ metabolite concentrations in plasma
MeNAM, NAM, DMG, TMG and Homocystein
Time frame: Day 0, Day 14 and Day 28
Change from baseline NAD+ metabolite concentrations in urine
MeNAM and Me-2-PY
Time frame: Day -7, Day 14 and Day 28
Adverse events
Evaluation of adverse events
Time frame: Day 14 and Day 28
Evolution of the mitochondrial DNA ratio
mitochondrial DNA ratio will be assessed in the epithelial cells collected by buccal swabs
Time frame: Day 0 and Day 28
Evolution of blood glucose levels
Time frame: Day -7, Day 14 and Day 28
Evolution of blood lipid levels
Triglycerides, Total Cholesterol, HDL-Cholesterol, LDL-Cholesterol
Time frame: Day -7, Day 14 and Day 28
Evolution of Transaminases (ASAT, ALAT, GGT) levels in blood
Time frame: Day -7, Day 14 and Day 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Evolution of Blood cell count
Time frame: Day -7, Day 14 and Day 28
Evolution of Bilirubin levels in blood
Time frame: Day -7, Day 14 and Day 28
Evolution of Creatinine levels in blood
Time frame: Day -7, Day 14 and Day 28
Creatine phosphokinase (CPK) levels in blood
Time frame: Day -7, Day 14 and Day 28
Evolution of blood Ionogram
Potassium, Chloride, Sodium levels will be assessed in blood
Time frame: Day -7, Day 14 and Day 28
Evolution of Diastolic blood pressure
Time frame: Day -7 and Day 28
Evolution of Systolic blood pressure
Time frame: Day -7 and Day 28
Evolution of Heart rate
Time frame: Day -7 and Day 28
Evolution of weight
Time frame: Day -7, Day 14 and Day 28
Evolution of body composition
Body composition will be assessed by impedancemetry
Time frame: Day -7, Day 14 and Day 28